Acumen Pharmaceuticals, Inc. — All Filings
328 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-3 | S-3 | 0001628280-26-021442 | Mar 26, 2026 | — |
| S-8 | S-8 | 0001628280-26-021418 | Mar 26, 2026 | — |
| 10-K | 10-K | 0001628280-26-021413 | Mar 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-021189 | Mar 26, 2026 | — |
| 4 | — | 0001231919-26-000262 | Mar 18, 2026 | Mar 16, 2026 |
| SCHEDULE 13D/A | — | 0001104659-26-029538 | Mar 17, 2026 | — |
| 8-K | 8-K | 0001628280-26-017885 | Mar 16, 2026 | Mar 13, 2026 |
| 4 | FORM 4 | 0001628280-26-016645 | Mar 10, 2026 | Mar 6, 2026 |
| 144 | — | 0001964306-26-000157 | Mar 6, 2026 | — |
| 4 | FORM 4 | 0001628280-26-014365 | Mar 3, 2026 | Feb 27, 2026 |
| 144 | — | 0001964306-26-000131 | Feb 27, 2026 | — |
| 4 | FORM 4 | 0001628280-26-003948 | Jan 28, 2026 | Jan 26, 2026 |
| 144 | — | 0001964306-26-000061 | Jan 28, 2026 | — |
| 144 | — | 0001964306-26-000060 | Jan 26, 2026 | — |
| 4 | FORM 4 | 0001628280-26-003349 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | FORM 4 | 0001628280-26-003348 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | FORM 4 | 0001628280-26-003347 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | FORM 4 | 0001628280-26-003346 | Jan 23, 2026 | Jan 21, 2026 |
| 4 | FORM 4 | 0001628280-26-003344 | Jan 23, 2026 | Jan 21, 2026 |
| 144 | — | 0001964306-26-000059 | Jan 23, 2026 | — |
| 144 | — | 0001964306-26-000058 | Jan 22, 2026 | — |
| 144 | — | 0001964306-26-000057 | Jan 22, 2026 | — |
| 144 | — | 0001964306-26-000056 | Jan 22, 2026 | — |
| 144 | — | 0001964306-26-000055 | Jan 22, 2026 | — |
| 144 | — | 0001964306-26-000054 | Jan 22, 2026 | — |
| 4 | FORM 4 | 0001628280-26-002962 | Jan 21, 2026 | Jan 20, 2026 |
| 4 | FORM 4 | 0001628280-26-002961 | Jan 21, 2026 | Jan 16, 2026 |
| 4 | FORM 4 | 0001628280-26-002960 | Jan 21, 2026 | Jan 16, 2026 |
| 4 | FORM 4 | 0001628280-26-002959 | Jan 21, 2026 | Jan 16, 2026 |
| 4 | FORM 4 | 0001628280-26-002958 | Jan 21, 2026 | Jan 16, 2026 |
| 4 | FORM 4 | 0001628280-26-002957 | Jan 21, 2026 | Jan 16, 2026 |
| 4 | FORM 4 | 0001628280-26-002956 | Jan 21, 2026 | Jan 16, 2026 |
| 144 | — | 0001964306-26-000052 | Jan 21, 2026 | — |
| 144 | — | 0001964306-26-000051 | Jan 21, 2026 | — |
| 144 | — | 0001964306-26-000050 | Jan 21, 2026 | — |
| 144 | — | 0001964306-26-000049 | Jan 21, 2026 | — |
| 144 | — | 0001964306-26-000048 | Jan 21, 2026 | — |
| 4 | FORM 4 | 0001628280-26-001898 | Jan 12, 2026 | Jan 8, 2026 |
| 4 | FORM 4 | 0001628280-26-001897 | Jan 12, 2026 | Jan 8, 2026 |
| 4 | FORM 4 | 0001628280-26-001896 | Jan 12, 2026 | Jan 8, 2026 |
| 4 | FORM 4 | 0001628280-26-001895 | Jan 12, 2026 | Jan 8, 2026 |
| 144 | — | 0001964306-26-000034 | Jan 12, 2026 | — |
| 144 | — | 0001964306-26-000033 | Jan 12, 2026 | — |
| 8-K | 8-K | 0001628280-26-001774 | Jan 12, 2026 | — |
| 4 | FORM 4 | 0001628280-26-001636 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | FORM 4 | 0001628280-26-001633 | Jan 9, 2026 | Jan 7, 2026 |
| 144 | — | 0001964306-26-000031 | Jan 9, 2026 | — |
| 144 | — | 0001964306-26-000030 | Jan 9, 2026 | — |
| 144 | — | 0001964306-26-000027 | Jan 8, 2026 | — |
| 144 | — | 0001964306-26-000026 | Jan 8, 2026 | — |